XML 50 R40.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Investment in Viking Therapeutics (Details) $ / shares in Units, $ in Thousands |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 13 Months Ended |  |
--- | --- | --- | --- | --- | --- | --- | ---
Apr. 13, 2016 USD ($) shares | Apr. 30, 2016 USD ($) $ / shares shares | Jan. 31, 2016 USD ($) | May 31, 2015 USD ($) $ / shares shares | May 31, 2014 USD ($) program | Jun. 30, 2016 USD ($) | Jun. 30, 2016 USD ($) | Jun. 30, 2015 USD ($) | May 31, 2015 $ / shares | Dec. 31, 2015 USD ($) | Aug. 31, 2014 $ / shares shares
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |
Payments to acquire IPO shares |  |  |  |  |  |  | $ 700 | $ 9,000 |  |  |
Warrants issued in public offering (shares) | shares |  |  |  |  |  |  |  |  |  |  | 3,264,643
Exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 125.08
Proceeds received from repayment of Viking note receivable |  |  |  |  |  |  | 300 | $ 0 |  |  |
Note receivable from Viking Therapeutics |  |  |  |  |  | $ 3,207 | 3,207 |  |  | $ 4,782 |
Change in fair value of the Viking convertible debt receivable and warrants |  |  |  |  |  | $ (200) | $ (200) |  |  |  |
Viking |  |  |  |  |  |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of programs licensed | program |  |  |  |  | 5 |  |  |  |  |  |
Loss percentage recorded |  |  |  |  |  |  |  |  | 100.00% |  |
Debt | Viking |  |  |  |  |  |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |
Convertible loan facility |  |  |  |  | $ 2,500 |  |  |  |  |  |
Viking Therapeutics, Inc. |  |  |  |  |  |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |
Shares issued in IPO (shares) | shares |  | 7,500,000 |  |  |  |  |  |  |  |  |
IPO share price (USD per share) | $ / shares |  | $ 1.25 |  |  |  |  |  |  |  |  |
IPO shares purchased by the Company (shares) | shares |  | 560,000 |  |  |  |  |  |  |  |  |
Payments to acquire IPO shares |  | $ 700 |  |  |  |  |  |  |  |  |
Equity interest in outstanding common stock of Viking (percent) |  | 32.70% |  |  |  | 32.70% | 32.70% |  |  |  |
Note receivable, stated interest rate (percent) |  |  | 2.50% |  |  |  |  |  |  | 5.00% |
LSA, lock-up period extension |  |  | 1 year |  |  |  |  |  |  |  |
Note receivable, amount due upon consummation of capital financing transaction |  |  | $ 1,500 |  |  |  |  |  |  |  |
Note receivable, cash due upon consummation of capital financing transaction |  |  | $ 300 |  |  |  |  |  |  |  |
Note receivable, repayment in equity (percent) |  |  | 200.00% |  |  |  |  |  |  |  |
Warrants issued in public offering (shares) | shares |  | 7,500,000 |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  | $ 1.50 |  |  |  |  |  |  |  |  |
Public offering warrants purchased by the Company (USD per share) | shares |  | 560,000 |  |  |  |  |  |  |  |  |
Proceeds received from repayment of Viking note receivable | $ 300 |  |  |  |  |  |  |  |  |  |
Shares received for repayment of note receivable (shares) | shares | 960,000 |  |  |  |  |  |  |  |  |  |
Equity Method Investment, Warrants Received, Licensing Agreement | shares | 960,000 |  |  |  |  |  |  |  |  |  |
Value of shares and warrants received for repayment of note receivable | $ 1,200 |  |  |  |  |  |  |  |  |  |
Decrease in investment in Viking |  | $ (10,000) |  |  |  |  |  |  |  |  |
Common Stock |  |  |  |  |  |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |
Aggregate value of shares received under licensing agreement |  |  |  | $ 29,200 |  |  |  |  |  |  |
IPO shares purchased by the Company (shares) | shares |  |  |  | 1,100,000 |  |  |  |  |  |  |
Payments to acquire IPO shares |  |  |  | $ 9,000 |  |  |  |  |  |  |
Common Stock | Viking Therapeutics, Inc. | IPO |  |  |  |  |  |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |
Shares issued in IPO (shares) | shares |  |  |  | 3,700,000 |  |  |  |  |  |  |
IPO aggregate offering price |  |  |  | $ 29,200 |  |  |  |  |  |  |
IPO share price (USD per share) | $ / shares |  |  |  | $ 8.00 |  |  |  |  | $ 8.00 |  |
Other Income |  |  |  |  |  |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |
Short term investment gain |  |  |  |  |  | $ 500 |  |  |  |  |

X
- Definition Equity Method Investment, Shares Received, Licensing Agreement + References No definition available. + Details
Name: | lgnd_EquityMethodInvestmentSharesReceivedLicensingAgreement
Namespace Prefix: | lgnd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity Method Investment, Value, Shares Received, Licensing Agreement + References No definition available. + Details
Name: | lgnd_EquityMethodInvestmentValueSharesReceivedLicensingAgreement
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investment, Warrants Received, Licensing Agreement + References No definition available. + Details
Name: | lgnd_EquityMethodInvestmentWarrantsReceivedLicensingAgreement
Namespace Prefix: | lgnd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity Method Investments, Shares Purchased + References No definition available. + Details
Name: | lgnd_EquityMethodInvestmentsSharesPurchased
Namespace Prefix: | lgnd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity Method Investments, Warrants Purchased + References No definition available. + Details
Name: | lgnd_EquityMethodInvestmentsWarrantsPurchased
Namespace Prefix: | lgnd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Increase (Decrease) in Equity Method Investment + References No definition available. + Details
Name: | lgnd_IncreaseDecreaseinEquityMethodInvestment
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Increase (Decrease) in Fair Value of Convertible Debt Receivable + References No definition available. + Details
Name: | lgnd_IncreaseDecreaseinFairValueofConvertibleDebtReceivable
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition License Agreement, Repayment in Equity, Repayment Percentage + References No definition available. + Details
Name: | lgnd_LicenseAgreementRepaymentinEquityRepaymentPercentage
Namespace Prefix: | lgnd_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loan Amendment, Lock-up Period Extension + References No definition available. + Details
Name: | lgnd_LoanAmendmentLockupPeriodExtension
Namespace Prefix: | lgnd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Note Receivable, Amount Due Upon Triggering Event + References No definition available. + Details
Name: | lgnd_NoteReceivableAmountDueUponTriggeringEvent
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Note Receivable, Cash Due Upon Triggering Event + References No definition available. + Details
Name: | lgnd_NoteReceivableCashDueUponTriggeringEvent
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Note Receivable, Stated Interest Rate + References No definition available. + Details
Name: | lgnd_NoteReceivableStatedInterestRate
Namespace Prefix: | lgnd_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Variable Interest Entity, Number of Programs Licensed + References No definition available. + Details
Name: | lgnd_VariableInterestEntityNumberofProgramsLicensed
Namespace Prefix: | lgnd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Variable Interest Entity, Qualitative or Quantitative Information, Loss Percentage Recorded + References No definition available. + Details
Name: | lgnd_VariableInterestEntityQualitativeorQuantitativeInformationLossPercentageRecorded
Namespace Prefix: | lgnd_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (c)-(e) -URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27357-111563 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7(c),9(a)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 10 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27405-111563 + Details
Name: | us-gaap_GainLossOnInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=65884687&loc=d3e4531-111522 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3(a),(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (c),(e) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 + Details
Name: | us-gaap_NotesAndLoansReceivableGrossCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The value of the noncash (or part noncash) consideration received in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586 + Details
Name: | us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585 + Details
Name: | us-gaap_ProceedsFromCollectionOfNotesReceivable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of financial or other support the reporting entity has provided (explicitly or implicitly) to the Variable Interest Entity (VIE) that it was not previously contractually required to provide or that the reporting entity intends to provide, including, for example, situations in which the reporting entity assisted the VIE in obtaining another type of support. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=64801991&loc=SL6759159-111685 + Details
Name: | us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=us-gaap_DebtMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |